Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical data discussed this week support clinical trials with thioplatin

April 9, 2002

European Commission designates E21R orphan drug in JMML

April 9, 2002

Adherex and AstraZeneca extend Exherin collaboration agreement

April 9, 2002

Independent review and long-term follow-up of phase II Orathecin study

April 9, 2002

Orally active VEGF receptor tyrosine kinase-selective agent presented at AACR meeting

April 9, 2002

Favorable pharmacokinetic profile seen for novel tyrosine kinase inhibitor CHIR-200131

April 9, 2002

Flt-3 kinase inhibitors and potential for treatment of AML discussed in Orlando by Millennium

April 9, 2002

LAQ-824: a potential new antitumor agent acting via inhibition of histone deacetylase

April 9, 2002

Promising profile reported at AACR meeting for novel histone deacetylase inhibitor CG-1521

April 9, 2002

Phase II studies of TOCOSOL Paclitaxel initiated

April 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...